Development Matters. (a) All preclinical and clinical studies conducted by or on behalf of the Company to support approval for commercialization of the Company’s products have been conducted by the Company, or to the Company’s knowledge by third parties, in compliance with all applicable federal, state or foreign laws, rules, orders and regulations, except for such failure or failures to be in compliance which would not reasonably be expected to have, singly or in the aggregate, a Material Adverse Effect.
Appears in 4 contracts
Samples: Stock Purchase Agreement (Voyager Therapeutics, Inc.), Stock Purchase Agreement (Voyager Therapeutics, Inc.), Stock Purchase Agreement (Neurocrine Biosciences Inc)
Development Matters. (a) All preclinical and clinical studies conducted by or on behalf of the Company to support approval for commercialization of the Company’s products or product candidates have been conducted by the Company, or to the Company’s knowledge by third parties, in compliance with all applicable federal, state or foreign laws, rules, orders and regulations, except for such failure or failures to be in compliance which would not reasonably be expected to have, singly or in the aggregate, a Material Adverse Effect.knowledge
Appears in 1 contract
Samples: Stock Purchase Agreement (Neurocrine Biosciences Inc)